Spectrum Science
Digital Dose: LinkedIn Tests Collaborative Posts, Meta Expands AI Content Reviews
Welcome to your dose of trending news from the digital universe, courtesy of the Spectrum Science Innovation Team.
In this edition of Digital Dose, we’re diving into LinkedIn testing a new feature that has the potential to reshape how brands and creators collaborate and share content and Meta’s continued shift toward AI-powered content moderation and ad reviews.
++
LinkedIn Tests Collaborative Posts Feature for Creators and Brands
LinkedIn is testing a new Collaborative Posts feature that lets members and company pages co-author and publish content together, with all collaborators displayed on a single shared post. The feature is designed to help brands, employees, executives, and partners expand reach across multiple audiences, with a broader rollout planned in the coming months.
Why it matters: LinkedIn’s new collaborative posting functionality has the potential to reshape how brands, executives, employees, and creators share content on the platform. By enabling multiple contributors to share ownership of a single post, organizations can amplify reach across audiences, strengthen employee advocacy efforts, and create more seamless partnership activations. As LinkedIn continues to invest in creator-focused tools, this feature may open new opportunities for companies to increase visibility, foster authentic engagement, and elevate collaborative storytelling around major announcements, milestones, and thought leadership initiatives.
Meta Plans to Replace 90% of Content Review Staff With AI
Meta is accelerating its use of AI for content moderation and ad reviews, with the goal of having AI handle up to 90% of these decisions by the end of 2026. While this shift could potentially improve efficiency, recent security issues have raised concerns about the risks of user-generated platforms relying too heavily on AI-powered systems.
Why it matters: This update underscores just how rapidly AI is becoming embedded across social platforms, for better or for worse. As Meta increasingly automates content moderation and ad review, brands should be prepared for inconsistencies, false flagging, or evolving enforcement decisions driven by AI systems. For highly regulated industries such as biotech and healthcare, this makes proactive compliance, clear messaging, and ongoing monitoring of campaign performance especially critical. It’s important to remain aware of ongoing changes to Meta platforms—including Facebook, Instagram, and Threads—and how content strategies may need to be reevaluated to align with evolving AI review standards.
++
Interested in more? Don’t miss these additional digital headlines:
- Google adds AI guidance to Demand Gen campaigns [SocialMediaToday]
- Clear messaging helps brands with AI optimization [SocialMediaToday]
- Social media’s next evolution: user-controlled algorithms [TechCrunch]
- Meta outlines best practices for AI-generated multimedia ads [SocialMediaToday]
Have questions or comments on the content of this blog? Contact us.
Perspectives
Spectrum Science
A Page by Page Summer Reading Challenge
Spectrum Science
Prioritizing Your Mental Elf in 2024
Spectrum Science
Spectrum Leaders Give 2024 Predictions for MM+M
Spectrum Science
Spectrum Science Acquires Continuum Clinical, Amplifying Patient Recruitment Capabilities